ICTUImperial Clinical Trials Unit

Welcome to Imperial Clinical Trials Unit (ICTU)

This website is intended for commercial trial sponsors engaged in the area of pharmaceuticals, medical devices or diagnostic devices

Cardiovascular and Diabetes

Led by outstanding clinical academics in the National Heart and Lung Institute (NHLI),  Imperial is at the forefront of the diagnosis, prevention and treatment of heart disease.  

Key areas of research include:

•Management of hypertension and dyslipidemia
•Prevention of cardiovascular disease
•Prevention and treatment of diabetes
•Evaluation of single-pill combination therapy
•Diagnosis of stenosis severity
•Management of arrhythmia
•Treatment of heart failure
•Treatment of aortic aneurysm

Under the guidance of Neil Poulter, Professor of Preventive Cardiovascular Medicine at Imperial College, ICTU has led and co-ordinated major cardiovascular and diabetes studies in these area across the UK, Europe and the globe.